Nephrology

For further information and guidance on how to treat your patients with Nephrotrans^® (sodium hydrogen carbonate), please download and read the SPC

Nephrotrans^® (sodium hydrogen carbonate)

Nephrotrans^® (sodium hydrogen carbonate) is indicated for the treatment of metabolic acidosis and for maintenance treatment against recurrence of metabolic acidosis in adults with chronic renal impairment.¹

Dosing & administration

• The dosage depends on the severity of metabolic acidosis, based on the results of blood gas analysis or determination of serum bicarbonate.
• The mean dosage is 3 to 5 g sodium hydrogen carbonate per day, equivalent to 40-65 mg sodium hydrogen carbonate per kg body weight per day.
• The daily dose can be achieved by taking 6 to 10 capsules of Nephrotrans 500 mg.¹
• To be swallowed whole throughout the day with sufficient liquid.¹
• This medicinal product should not be taken without medical supervision for prolonged periods, as there is a possibility for the development of hypernatremia or alkalosis.¹

Note: Patients with a blood pH level below 7.2 require the correction of acidosis by infusion.¹

Safety and Monitoring

Access our full safety and monitoring information or please refer to section 4 of the SPC.

Availability

Nephrotrans^® is now available to prescribe in the UK. To arrange a visit with your local MEDICE UK Key Account Manager please click below.